The statin saga – do they help or harm? – took a fascinating new turn on Sunday when statin supremo Professor Sir Rory Collins confessed to the Express that he hadn’t actually done the analysis needed to uncover the true side-effect rate.

If you’ve been following this pharmacological soap, your response when you heard this was probably first amazed laughter, followed by outrage at the breath-taking hypocrisy and then, after a brief reflection, alarm at the implications.

 Welcome to a new episode […]

Liraglutide hit the headlines in January because it had just been approved by the European Medicines Agency (EMA) for the treatment of obesity, to be marketed as “Saxenda”. The EMA had previously approved it for type 2 diabetes in July 2009. In America the approval for obesity had come a month earlier in December 2014.

Developing a safe and effective […]